The Fourth Annual World Congress on Industrial Biotechnology and Bioprocessing brings together thought leaders, investors, researchers and business executives in industrial biotechnology, bioenergy and bioprocessing. This year's conference presents the latest issues, innovations, market achievements and policy developments in the industrial and environmental applications of biotechnology.
From biofuels to cosmetics, intellectual property (IP) plays a central role in the development of industrial biotechnology. Critical to achieving commercial success is knowing how to protect and leverage a company’s technology while avoiding the IP rights of others. Accordingly, IP Senior Counsel Brian McCaslin will lead a panel discussion of effective strategies for protecting IP assets and for avoiding obstacles on the path to commercialization. Mr. McCaslin is a member of the Biotechnology & Pharmaceutical Practice at Foley, where he counsels life-science companies and funds on the strategic acquisition and use of intellectual property.